Changes in Graves’ Ophthalmopathy after Radioiodine and Anti-Thyroid Drug Treatment of Graves’ Disease from 2 Prospective, Randomized, Open-Label, Blinded End Point Studies-Reference-Cited by-同舟云学术

Changes in Graves’ Ophthalmopathy after Radioiodine and Anti-Thyroid Drug Treatment of Graves’ Disease from 2 Prospective, Randomized, Open-Label, Blinded End Point Studies

Published:2013-11-07 Issue:01 Volume:122 Page:1-6
ISSN:0947-7349
Container-title:Experimental and Clinical Endocrinology & Diabetes
language:en
Short-container-title:Exp Clin Endocrinol Diabetes

Author:

Chen D.¹,Schneider P.²,Zhang X.¹,Luo X.³,He Z.⁴,Chen T.¹

Affiliation:

1. Department of Nuclear Medicine of The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

2. Clinic for Nuclear Medicine, University Hospital, Würzburg, Germany

3. Ophthalmology Division, Guangdong General Hospital, Guangzhou, China

4. Department of Internal Medicine of The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

Publisher

Georg Thieme Verlag KG

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0033-1358484.pdf

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparison of cardiovascular disease, cancer, mortality, and Graves' ophthalmopathy following treatment for hyperthyroidism: A Bayesian network meta‐analysis;World Journal of Surgery;2024-01-18

2. DGN-Handlungsempfehlung (S1-Leitlinie): Radiojodtherapie bei benignen Schilddrüsenerkrankungen (Stand 6/2022 – AWMF-Registernummer: 031-003) – Radiojodtherapie bei benignen Schilddrüsenerkrankungen;Nuklearmedizin - NuclearMedicine;2023-10-23

3. RhoA with Associated TRAb or FT3 in the Diagnosis and Prediction of Graves’ Ophthalmopathy;Disease Markers;2022-07-29

4. Case series of Euthyroid Graves’ Ophthalmopathy in patients seronegative for TSH receptor autoantibody (TRAb) & developed Hyperthyroidism in follow-up visits;Indian Journal of Clinical and Experimental Ophthalmology;2022-06-15

5. Long-term outcome of patients treated with antithyroid drugs, radioactive iodine or surgery for persistent or relapsed Graves’ disease;British Journal of Surgery;2022-02-07